V. A. Levin

728 total citations
25 papers, 542 citations indexed

About

V. A. Levin is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, V. A. Levin has authored 25 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in V. A. Levin's work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (6 papers) and Neuroblastoma Research and Treatments (4 papers). V. A. Levin is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (6 papers) and Neuroblastoma Research and Treatments (4 papers). V. A. Levin collaborates with scholars based in United States and Russia. V. A. Levin's co-authors include Risa Kagan, Xuezhi Jiang, Luis A. Rodríguez, Ronald E. Talcott, Michael Rosenblum, M. L. Rosenblum, Massimo Gerosa, Jinhua Wen, Michael D. Prados and Daniel E. Furst and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

V. A. Levin

25 papers receiving 518 citations

Peers

Countries citing papers authored by V. A. Levin

Since Specialization

Citations

This map shows the geographic impact of V. A. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. A. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. A. Levin more than expected).

Fields of papers citing papers by V. A. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. A. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. A. Levin. The network helps show where V. A. Levin may publish in the future.

Co-authorship network of co-authors of V. A. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of V. A. Levin. A scholar is included among the top collaborators of V. A. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. A. Levin. V. A. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estrogen therapy for osteoporosis in the modern era 2018 ·Osteoporosis International ·V. A. Levin, Xuezhi Jiang, Risa Kagan	197
2	The reserves for improvement of quality of oocytes in polycystic ovarian syndrome 2017 ·Russian Journal of Human Reproduction ·(unknown), (unknown), (unknown), (unknown), V. A. Levin, (unknown), (unknown), (unknown)	1
3	Improvement in quality of oocytes in polycystic ovarian syndrome in programs of in vitro fertilization 2017 ·Gynecological Endocrinology ·(unknown), (unknown), (unknown), (unknown), V. A. Levin, (unknown), (unknown), (unknown)	15
4	A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma 2010 ·Neuro-Oncology ·Mark R. Gilbert, Javier Gonzalez, Kathy Hunter, Kenneth R. Hess, Pierre Giglio, Edward I. Chang, Vinay K. Puduvalli, Morris D. Groves, Howard Colman, C. Conrad, V. A. Levin, Shiao Y. Woo, Anita Mahajan, John de Groot, W.K. Alfred Yung	30
5	Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. 2010 ·Journal of Clinical Oncology ·Tobias Walbert, M. R. Gilbert, Morris D. Groves, Vinay K. Puduvalli, WK Alfred Yung, Charles A. Conrad, George C. Bobustuc, Howard Colman, B. Nebiyou Bekele, V. A. Levin	1
6	Final results of a phase I trial with the novel anthracycline derivative RTA 744 in patients with primary brain tumors 2007 ·Journal of Clinical Oncology ·Charles A. Conrad, E.J. Maher, Timothy F. Cloughesy, Morris D. Groves, Mark R. Gilbert, Timothy Madden, V. A. Levin, Waldemar Priebe, (unknown), W.K. Alfred Yung	2
7	Phase II study of the combination of thalidomide and irinotecan in patients with recurrent anaplastic gliomas not on enzyme inducing anticonvulsants 2006 ·Journal of Clinical Oncology ·Vinay K. Puduvalli, Pierre Giglio, Morris D. Groves, Kenneth R. Hess, M. Jean Gilbert, Srikanth Mahankali, (unknown), Howard Colman, C. Conrad, V. A. Levin, W. K. Alfred Yung	2
8	Phase II trial of thalidomide in combination with irinotecan in adults with recurrent glioblastoma multiforme 2005 ·Journal of Clinical Oncology ·Vinay K. Puduvalli, Pierre Giglio, Morris D. Groves, Kenneth R. Hess, Edward F. Jackson, Srikanth Mahankali, M. Jean Gilbert, V. A. Levin, C. Conrad, (unknown), W.K. Alfred Yung	3
9	Phase II study of 6-thioguanine, procarbazine, dibromodulcitol,lomustine, and vincristine chemotherapy with radiotherapy for treatingmalignant glioma in children 2000 ·Neuro-Oncology ·V. A. Levin, Kathleen R. Lamborn, William M. Wara, Richard P. Davis, Michael J. Edwards, Jane Rabbitt, Mary Malec, Michael D. Prados	7
10	Primary central nervous system lymphoma: a role for adjuvant chemotherapy 1992 ·Journal of Neuro-Oncology ·(unknown), V. A. Levin	51
11	Management of hypothalamic gliomas in children 1990 ·Neurosurgery ·Luis A. Rodríguez, (unknown), V. A. Levin	54
12	Forbeck Forum On Improved Drug Delivery to Brain Tumors 1990 ·PubMed ·(unknown), J. Fenstermacher, William Shapiro, J T Kemshead, Mark Chasin, O. Michael Colvin, Mirko Dikšić, (unknown), Andrew Hertler, V. A. Levin, (unknown), (unknown), (unknown), (unknown)	3
13	Treatment of extraneural metastatic medulloblastoma with a combination of cyclophosphamide, adriamycin, and vincristine 1988 ·Neurosurgery ·Marc C. Chamberlain, Pamela Silver, (unknown), V. A. Levin	1
14	Malignant Supratentorial Gliomas in Childhood 1987 ·Pediatric Neurosurgery ·Michael D. Prados, V. A. Levin	6
15	l-fucose labeling of brain tumors in rats 1986 ·Experimental Neurology ·Griffith R. Harsh, Robert N. Nishimura, Barney E. Dwyer, V. A. Levin	6
16	Possible role of DT-diaphorase in the bioactivation of antitumor quinones 1983 ·Biochemical and Biophysical Research Communications ·Ronald E. Talcott, Michael Rosenblum, V. A. Levin	32
17	Phase II evaluation of thioTEPA for treatment of central nervous system tumors. 1979 ·PubMed ·Margaret Edwards, V. A. Levin, (unknown), (unknown), (unknown)	11
18	Analysis for 1,3-bis(2-chloroethyl)-1-nitrosourea by chemical ionization mass spectrometry. 1978 ·Clinical Chemistry ·(unknown), Jinhua Wen, Daniel E. Furst, V. A. Levin	17
19	Development of Hodgkin's disease in a patient receiving procarbazine, CCNU, and vincristine therapy for a gemistocytic astrocytoma. 1978 ·PubMed ·David C. Crafts, (unknown), (unknown), V. A. Levin	2
20	Uptake and distribution of 3h-methotrexate by the murine ependymo- blastoma. 1972 ·The Mouseion at the JAXlibrary (Jackson Laboratory) ·V. A. Levin, (unknown), (unknown), David P. Rall	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact